RTX's Raytheon awarded $20.7 billion multi-year contract for AMRAAM under landmark production agreement
Contract accelerates production ramp as part of Department of War's Arsenal of Freedom
This contract follows the landmark agreement between Raytheon and the Department of War announced earlier this year, which supports the annual production of at least 1,900 AMRAAM missiles.
"AMRAAM remains the world's most trusted, combat-proven air dominance weapon for
RTX has invested heavily in recent years to ramp production of AMRAAM and other critical munitions, nearly doubling production in 2025 compared to 2024. By collaborating closely with hundreds of small and mid-sized suppliers nationwide — and now exploring international co-production — RTX is rapidly scaling output to meet long-term operational requirements.
Now in its fifth generation, AMRAAM operates on 14 platforms and is fielded by 44 countries, achieving more than 7,000 successful live fires in test and combat. Upgraded with advanced processors that allow for agile software updates to outpace current and future threats, it serves as the primary interceptor for both air-to-air missions and the NASAMS® air defense system.
About Raytheon
Raytheon, an RTX business, is a leading provider of defense solutions to help the
About RTX
With more than 180,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. With industry-leading capabilities, we advance aviation, engineer integrated defense systems for operational success, and develop next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2025 sales of more than $88 billion, is headquartered in Arlington, Virginia.
For questions or to schedule an interview, please contact [email protected].
View original content:https://www.prnewswire.com/news-releases/rtxs-raytheon-awarded-20-7-billion-multi-year-contract-for-amraam-under-landmark-production-agreement-302891969.html
SOURCE RTX
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids
- Statement From Granite Telecommunications
- Asuri.ai Launches Multi-Agent AI Platform for Persistent Business Workflows
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share